Resonance Specialties Limited (BOM:524218)

Market Cap	1.08B
Revenue (ttm)	852.48M
Net Income (ttm)	74.60M
Shares Out	11.54M
EPS (ttm)	6.47
PE Ratio	14.46
Forward PE	n/a
Dividend	1.00 (1.05%)
Ex-Dividend Date	Jul 29, 2025

Volume	1,783
Average Volume	5,279
Open	95.00
Previous Close	94.15
Day's Range	95.00 - 97.95
52-Week Range	65.00 - 124.50
Beta	-0.19
RSI	38.44
Earnings Date	Feb 4, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 66
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In 2024, Resonance Specialties's revenue was 778.07 million, an increase of 40.70% compared to the previous year's 553.01 million. Earnings were 65.66 million, an increase of 121.20%.